MLTX
MoonLake Immunotherapeutics · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -22.3% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 59 | +3 | 21.61M | $421.37M | +4 | −1 |
| Q1 2026 | 59 | +5 | 21.19M | $393.03M | +8 | −3 |
| Q4 2025 | 55 | +1 | 18.04M | $237.83M | +3 | −2 |
| Q3 2025 | 15 | +2 | 5.30M | $38.02M | +3 | −1 |
| Q2 2025 | 10 | -1 | 11.33M | $534.65M | +1 | −2 |
| Q1 2025 | 8 | 0 | 5.66M | $221.05M | +2 | −2 |
| Q4 2024 | 8 | 0 | 7.28M | $394.17M | +1 | −1 |
| Q3 2024 | 7 | 0 | 7.26M | $366.27M | — | — |
| Q2 2024 | 7 | — | 8.40M | $369.30M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 2.97M | -11.1% | $116.19M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.48M | -32.4% | $57.77M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.48M | -32.4% | $57.77M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | Marshall Wace ✦ | 640.92K | -48.5% | $25.04M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Marshall Wace ✦ | 640.92K | -48.5% | $25.04M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Millennium Management ✦ | 344.32K | Nuevo | $13.45M | 0.0% | New | 1 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (pasivo) | 93.40K | +2.0% | $3.65M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasivo) | 58.99K | +0.1% | $2.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 35.64K | Nuevo | $1.39M | 0.0% | New | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 32.16K | -67.5% | $1.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 32.16K | -67.5% | $1.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Wellington Management ✦ | 32.16K | -67.5% | $1.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Millennium Management | $13.45M | 0.0% |
| Two Sigma Investments | $1.39M | 0.0% |
Posición cerrada
| Adage Capital Partners | $8.39M | era 0.0% |
| Point72 Asset Management | $5.35M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 145 tenedores, 61.96M acciones, $1.12B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.